In our SAH mouse model, we showed that adropin was effective against subarachnoid hemorrhage-mediated neural injury and delayed cerebral infarction through eNOS-dependent mechanisms [174]. The gene discussed is ENHO; the disease is subarachnoid hemorrhage.